Clinical Trial

Vitamin B6 Aids in Treating Inflammatory Bowel Disease

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment, exploring whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect of IBD patients.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06512441
Lead Sponsor Changhai Hospital
Conditions Inflammatory Bowel Diseases
Enrollment 220 participants
Start Date 2024-06-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-22